Pierrefite-Carle V, Baqué P, Gavelli A, Brossette N, Benchimol D, Bourgeon A, Saint Paul M C, Staccini P, Rossi B
Unité INSERM 364, IFR 50, Faculté de Médecine, Avenue de Valombrose, 06107 Nice cedex 2, France.
Gut. 2002 Mar;50(3):387-91. doi: 10.1136/gut.50.3.387.
Suicide gene therapy consists of the transfer into tumour cells of a "suicide" gene that can convert a non-toxic compound into a lethal drug. Expression of the cytosine deaminase gene leads to the conversion of the non-toxic compound 5-fluorocytosine to 5-fluorouracil. We have recently shown that "suicide cell based vaccination" consisting of intrahepatic injection of cytosine deaminase expressing colon cancer cells followed by 5-fluorocytosine treatment induces regression of a distant wild-type liver tumour in rats.
This study was conducted to test if (i) a distant bystander effect on a liver tumour can be induced after subcutaneous suicide cell based vaccination and (ii) suicide cell based vaccination is efficient in limiting tumour dissemination to extrahepatic compartments.
An aggressive variant of rat colon carcinoma cells was selected after successive passages in vitro. Rats carrying an experimental liver "metastasis" generated by injection of these cells were vaccinated by subcapsular or subcutaneous injection of cytosine deaminase expressing cells followed by 5-fluorocytosine treatment.
Subcutaneous and subcapsular vaccination induced 70% regression in the median volume of the pre-established liver tumour (p=0.001) and abolished tumour dissemination compared with control animals.
This study has compared for the first time the efficiency of subcutaneous and intrahepatic suicide cell based vaccination in a metastatic colorectal carcinoma model in rats. The results indicate that both modes of vaccination are equally efficient in inducing a systemic antitumour response, suggesting that this strategy is a powerful approach against the development and dissemination of metastatic colon carcinoma.
自杀基因疗法是将一种“自杀”基因导入肿瘤细胞,该基因可将无毒化合物转化为致死性药物。胞嘧啶脱氨酶基因的表达可导致无毒化合物5-氟胞嘧啶转化为5-氟尿嘧啶。我们最近发现,“基于自杀细胞的疫苗接种”,即肝内注射表达胞嘧啶脱氨酶的结肠癌细胞,随后进行5-氟胞嘧啶治疗,可诱导大鼠远处野生型肝肿瘤消退。
本研究旨在测试(i)皮下基于自杀细胞的疫苗接种后是否能诱导对肝肿瘤的远处旁观者效应,以及(ii)基于自杀细胞的疫苗接种在限制肿瘤向肝外区域扩散方面是否有效。
在体外连续传代后筛选出大鼠结肠癌细胞的侵袭性变体。通过包膜下或皮下注射表达胞嘧啶脱氨酶的细胞,随后进行5-氟胞嘧啶治疗,对携带由注射这些细胞产生的实验性肝“转移瘤”的大鼠进行疫苗接种。
与对照动物相比,皮下和包膜下疫苗接种使预先建立的肝肿瘤中位体积缩小了70%(p = 0.001),并消除了肿瘤扩散。
本研究首次比较了皮下和肝内基于自杀细胞的疫苗接种在大鼠转移性结直肠癌模型中的效率。结果表明,两种疫苗接种方式在诱导全身抗肿瘤反应方面同样有效,表明该策略是对抗转移性结肠癌发生和扩散的有力方法。